US FDA commissioner nominee might employ modular specialists to work with review divisions on issues related to gene therapies, molecularly-targeted drugs, adaptive clinical trial designs, or other complex issues.
Sen. Lamar Alexander meets with FDA Commissioner nominee Dr. Scott Gottlieb in Alexander’s Washington, D.C., office. A confirmation hearing is expected to be scheduled once the HELP Committee receives Gottlieb's Office of Government Ethics paperwork. • Source: Courtesy of Sen. Alexander’s office
